|
|||||
|
|
Selective and enantiospecific acylation of kappa opioid receptors by (1S,2S)-trans-2-isothiocyanato-N-methyl-N-[2-(1-pyrrolidinyl) cyclohexy l] benzeneacetamide. Demonstration of kappa receptor heterogeneity |
|
| Authors: | B R de Costa R B Rothman V Bykov A E Jacobson K C Rice |
| Affiliation: | Section on Drug Design and Synthesis, National Institute of Digestive, Diabetes and Kidney Diseases, Bethesda, Maryland 20892. |
| Abstract: | |
| Keywords: | |